COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...
Lipid nanoparticles, or LNPs, are best known as the delivery system used in the COVID-19 mRNA vaccines given to billions of people worldwide. Scientists are now exploring their potential far beyond ...
3d
Simple 'cocktail' of amino acids dramatically boosts power of mRNA therapies and CRISPR gene editing
Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution. Researchers ...
Some members of the CDC’s vaccine advisory panel have publicly questioned the safety and manufacturing of the shots, including raising a debunked theory that DNA contaminants in the vaccines are ...
Some members of the CDC’s vaccine advisory panel have publicly questioned the safety and manufacturing of the shots, including raising a debunked theory that DNA contaminants in the vaccines are ...
BioNTech (NASDAQ:BNTX) management outlined a strategy centered on late-stage oncology execution and combination-based development during the company’s fourth-quarter and full-year 2025 earnings call, ...
6d
From cancer tests to COVID vaccines: the women reshaping Europe’s health in a male-dominated field
Despite a surge in female scientists across the continent, women account for just 13 percent of European inventors.View on ...
For instance, researchers noticed during the pandemic that people who received the BCG vaccine against tuberculosis—which is not recommended in the U.S. but is commonly used in countries where the ...
Major health care policy changes under the Trump administration have driven some professional medical organizations to take different approaches to their advocacy strategies.During President Donald J.
European regulators advanced several new medicines, including a combined flu and COVID vaccine and new treatments for rare diseases.
Moderna agreed to pay up to $2.25 billion to settle a long‑running COVID vaccine patent dispute. The deal ends years of legal ...
Researchers at University California San Diego School of Medicine have found that a natural fungal supplement taken at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results